Ellen James, PhD

Ellen James
Ellen James, PhD

Director of R&D

Ellen has 12 years’ experience in research, development and clinical project management. Following a PhD and post-doc at Imperial College London, she joined Trio Medicines in 2014, a pharmaceutical subsidiary of the Phase 1 CRO Hammersmith Medicines Research. There she was responsible for the development programmes of new chemical entities, as well as project managing several Phase 1 and 2 clinical studies.

During her career, Ellen has worked with regulatory agencies such as MHRA, EMA and FDA; managed teams of scientists; and managed subcontractors for CMC, nonclinical studies and clinical trials; she also has experience of the ICH guidelines and GxP environments. 

Ellen joined Small Pharma as Clinical Research Manager in 2017.

About Small Pharma

We’re a mental health drug development company that’s accelerating the development of fast acting antidepressant treatments using DMT based therapies. We’re dedicated to making a difference.

Get Small Pharma
Investor Updates

    Investor Deck

    Follow us: